{"artifact":{"id":"paper-fig-588c433b-f1be-4c39-8b46-7af2478ca834-6","artifact_type":"paper_figure","entity_ids":"[]","title":"Fig. 5: Diverse drug loading strategies employed by viable macrophages as carriers for d...","quality_score":0.5,"created_by":"paper_figures_pipeline","provenance_chain":"[{\"source\": \"paper\", \"paper_id\": \"588c433b-f1be-4c39-8b46-7af2478ca834\", \"relation\": \"extracted_from\"}]","content_hash":"b82200b875e59fe90a1c1b520858f3bf85b44abe36fda9f9277bb67d4a634b40","metadata":{"doi":"10.1016/j.ajps.2025.101063","pmcid":"PMC12552155","_origin":{"url":"https://www.ebi.ac.uk/europepmc/articles/PMC12552155/bin/gr5.jpg","type":"external","tracked_at":"2026-04-27T11:55:42.669323"},"caption":"Diverse drug loading strategies employed by viable macrophages as carriers for drug delivery. (A) Direct incubation with chemotherapeutic agents; (B) Internalization of NPs; (C) Ligand–receptor attachment; (D) Covalent coupling; (E) Other genetic modification processes, such as macrophages knocked out of SIRP- α  gene by the CRISPR-Cas9 gene editing mechanism; (F) Delivery of oncolytic virus (OV).","paper_id":"588c433b-f1be-4c39-8b46-7af2478ca834","image_url":"https://www.ebi.ac.uk/europepmc/articles/PMC12552155/bin/gr5.jpg","image_path":"","description":"","figure_label":"Fig. 5","figure_number":6,"_schema_version":1,"source_strategy":"pmc_api","entities_mentioned":""},"created_at":"2026-04-27T04:55:42.669504-07:00","updated_at":"2026-04-27T04:55:42.669504-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"external","origin_url":"https://www.ebi.ac.uk/europepmc/articles/PMC12552155/bin/gr5.jpg","lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"6a37f6a0-cae6-4751-b16d-bc0b8ea371f4","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"paper_figures_pipeline"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[],"incoming_links":[],"current_artifact_id":"paper-fig-588c433b-f1be-4c39-8b46-7af2478ca834-6","is_canonical":true,"supersede_chain":["paper-fig-588c433b-f1be-4c39-8b46-7af2478ca834-6"]}